Copia Partners and link to fund...
https://www.copiapartners.com.au/
https://www.chesteram.com.au/chester-high-conviction-fund
Botanix (BOT) also fell
in May as selling emerged after the Trump administration’s attempt to
reign in pharmaceutical pricing in the US as they focus on the Most
Favored Nation (MFN) clause, to ensure US pricing of pharmaceuticals is
not out of whack with international pricing. Curiously BOT does not sell
Sodfra internationally, so there is no international pricing comparison.
The product launch of Sodfra in the US appears to be tracking to plan
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.0¢ | $3.657M | 21.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 180978 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 529694 | 12 |
View Market Depth
| Last trade - 16.18pm 28/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |